Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zegocractin by CalciMedica for Pancreatitis: Likelihood of Approval
Zegocractin is under clinical development by CalciMedica and currently in Phase II for Pancreatitis. According to GlobalData, Phase II drugs...
Zegocractin by CalciMedica for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Zegocractin is under clinical development by CalciMedica and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According to...
Zegocractin by CalciMedica for Acute Renal Failure (ARF) (Acute Kidney Injury): Likelihood of Approval
Zegocractin is under clinical development by CalciMedica and currently in Phase II for Acute Renal Failure (ARF) (Acute Kidney Injury)....